After more than one century from Alois Alzheimer and Gaetano Perusini's first report, progress has been made in understanding the pathogenic steps of Alzheimer's disease (AD), as well as in its early diagnosis. This review discusses recent findings leading to the formulation of novel criteria for diagnosis of the disease even in a preclinical phase, by using biological markers. In addition, treatment options will be discussed, with emphasis on new disease-modifying compounds and future trial design suitable to test these drugs in an early phase of the disease.
Progress in Alzheimer's disease / D. Galimberti, E. Scarpini. - In: JOURNAL OF NEUROLOGY. - ISSN 0340-5354. - 259:2(2012 Feb), pp. 201-211. [10.1007/s00415-011-6145-3]
Progress in Alzheimer's disease
D. GalimbertiPrimo
;E. ScarpiniUltimo
2012
Abstract
After more than one century from Alois Alzheimer and Gaetano Perusini's first report, progress has been made in understanding the pathogenic steps of Alzheimer's disease (AD), as well as in its early diagnosis. This review discusses recent findings leading to the formulation of novel criteria for diagnosis of the disease even in a preclinical phase, by using biological markers. In addition, treatment options will be discussed, with emphasis on new disease-modifying compounds and future trial design suitable to test these drugs in an early phase of the disease.File | Dimensione | Formato | |
---|---|---|---|
10. Galimberti&Scarpini.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
222.96 kB
Formato
Adobe PDF
|
222.96 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.